Prostamax vs Testagen — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Prostamax is a tetrapeptide bioregulator (Ala-Glu-Asp-Gly) developed by the Khavinson Institute, targeted to prostate tissue support. Like other Khavinson bioregulators, it is proposed to act by entering prostate epithelial cells and modulating gene expression to normalize tissue...
Calculate Prostamax dose →Testagen is a tripeptide bioregulator (Lys-Asp-Glu) from the Khavinson Institute, targeted to testicular tissue support and reproductive function. It is proposed to normalize Leydig cell function and spermatogenesis by acting as a gene expression regulator in testicular tissue....
Calculate Testagen dose →| Parameter | Prostamax | Testagen |
|---|---|---|
| Category | Organ Support | Organ Support |
| Research | Research Use (CIS) | Research Use (CIS) |
| Half-Life | - | - |
| Typical Dose | 1–2 mg/day | 1–2 mg/day |
| Frequency | Daily | Daily |
| Route | Intramuscular | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.